Alert detail
Proposed LCD DL40474: MolDX: Genome-Wide Molecular Methodologies for the Detection of Copy Number Alterations and Structural Variants in Hematologic Neoplasms — WPS
Policy ID: LCD-DL40474Specialty: OncologyAdded: 9/24/2026lcd
What changed
Proposed LCD: Genome-wide CNV/SV testing in blood cancers—comment by 11/7/26
Who’s affected: Oncology billing teams
Primary source: View the official CMS/MAC document ↗
Get the action steps and full analysis
This change affects 10 billing codes.
The full analysis, the revision comparison and the as-of-date version of this policy are what a partner packet carries. The source document above is free and always will be.